Status:
COMPLETED
Reduction of COVID 19 Transmission to Health Care Professionals
Lead Sponsor:
Hanane EL KENZ
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
When the COVID-19 virus infects a person, it enters the lung epithelial cells of its host and uses its genetic material to replicate. The pulmonary epithelial cells of a part of the population, known...
Eligibility Criteria
Inclusion
- COVID19 positive patients admitted within the CHU Brugmann Hospital
Exclusion
- None
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 11 2022
Estimated Enrollment :
566 Patients enrolled
Trial Details
Trial ID
NCT04462627
Start Date
April 14 2020
End Date
April 11 2022
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020